[ad_1] BOSTON, Sept. 8, 2024 /PRNewswire/ — Antennova, a clinical-stage biotech company focused on oncology today announced that it will present the latest data of CD73 small molecule inhibitor ATN-037 in a Mini Oral presentation at […]